Gerard John Hatheway, PHARMD in Bonner, MT - Pharmacist

Gerard John Hatheway, PHARMD is a Pharmacist based in Bonner, Montana. Gerard John Hatheway is licensed to practice in Montana (license number 4941) and his current practice location is 855 Swanson Ln, Bonner, Montana. He can be reached at his office (for appointments etc.) via phone at (406) 546-9805.

NPI number for Gerard John Hatheway is 1033486220 and his current mailing address is 855 Swanson Ln, Bonner, Montana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1033486220.

Contact Information

	Gerard John Hatheway, PHARMD
	855 Swanson Ln, Bonner, MT 59823-9754
	(406) 546-9805
	(405) 244-7959

Healthcare Provider's Profile

Full Name	Gerard John Hatheway
Gender	Male
Speciality	Pharmacist
Location	855 Swanson Ln, Bonner, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1033486220
Provider Enumeration Date: 11/16/2011
Last Update Date: 11/16/2011

Medical Identifiers

Medical identifiers for Gerard John Hatheway such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033486220	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	4941 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gerard John Hatheway is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gerard John Hatheway, PHARMD 855 Swanson Ln, Bonner, MT 59823-9754 Ph: (406) 546-9805	Gerard John Hatheway, PHARMD 855 Swanson Ln, Bonner, MT 59823-9754 Ph: (406) 546-9805

News Archive

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

The New England Journal of Medicine (NEJM) published a study today that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET).

Common rubber products can cause contact allergy: Study

Common rubber products can form isothiocyanates in contact with skin and cause contact allergy. This is the conclusion of research carried out at the University of Gothenburg. Isothiocyanates are a group of reactive substances that are potent contact allergens.

FEBS and Elsevier's new journal to benefit scientific community

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Federation of Biochemical Societies (FEBS) announced today the launch of FEBS Open Bio, an open access journal.

Tart cherries may help reduce chronic inflammation in people with osteoarthritis

Tart cherries may help reduce chronic inflammation, especially for the millions of Americans suffering from debilitating joint pain and arthritis, according to new research from Oregon Health & Science University presented today at the American College of Sports Medicine Conference (ACSM) in San Francisco, Calif.

N.J.'s Christie joins ranks of GOP govs to opt to expand Medicaid

The decision by Gov. Chris Christie would provide health insurance to an estimated 104,000 of the poorest 1.3 million uninsured residents of the state. With this move, Christie follows other Republican governors who were staunch opponents of the health law, including Ohio's John Kasich and Florida's Rick Scott.

Gerard John Hatheway, PHARMD - Pharmacist in Bonner, MT